Study of Debio 1450 for Bacterial Skin Infections
Public ClinicalTrials.gov record NCT02426918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Multicenter Study of Safety, Tolerability, and Efficacy of Debio 1450 vs Vancomycin (IV)/Linezolid (Oral) in the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Due to Staphylococcus Sensitive or Resistant to Methicillin
Study identification
- NCT ID
- NCT02426918
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Debiopharm International SA
- Industry
- Enrollment
- 330 participants
Conditions and interventions
Conditions
Interventions
- Debio 1450 IV Drug
- Debio 1450 Oral Drug
- Debio 1450 Oral Placebo Drug
- Linezolid Drug
- Linezolid Placebo Drug
- Vancomycin IV Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015
- Primary completion
- Jul 31, 2016
- Completion
- Aug 31, 2016
- Last update posted
- Nov 12, 2019
2015 – 2016
United States locations
- U.S. sites
- 22
- U.S. states
- 9
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dream Team Clinical Research, LLC | Anaheim | California | 91776 | — |
| Physician Alliance Research Center | Anaheim | California | 92804 | — |
| Southbay Pharma Research | Buena Park | California | 90620 | — |
| eStudySite - Chula Vista | Chula Vista | California | 91911 | — |
| eStudySite - La Mesa | La Mesa | California | 91942 | — |
| Long Beach Clinical Trials LLC | Long Beach | California | 90806 | — |
| Alliance Research | Long Beach | California | 90813 | — |
| Central Valley Research, LLC | Modesto | California | 95350 | — |
| eStudySite - Oceanside | Oceanside | California | 92056 | — |
| Olive View - UCLA Medical Center | Sylmar | California | 91342 | — |
| Shands Burn Center at the University of Florida | Gainesville | Florida | 32610 | — |
| Central Florida Internists | Orlando | Florida | 32811 | — |
| Triple O Research Institute | West Palm Beach | Florida | 33401 | — |
| Columbus Regional Research | Columbus | Georgia | 31904 | — |
| Beaumont Infectious Disease Services | Royal Oak | Michigan | 48073 | — |
| Mercury Street Medical Group PLLC | Butte | Montana | 59701 | — |
| eStudySite - Las Vegas | Las Vegas | Nevada | 89109 | — |
| South Jersey Infectious Disease | Somers Point | New Jersey | 08244 | — |
| Holy Name Medical Center | Teaneck | New Jersey | 07666 | — |
| ID Clinical Research, Ltd. | Toledo | Ohio | 43608 | — |
| East Montgomery County Clinic | Houston | Texas | 77070 | — |
| Tidwell Medical Center | Splendora | Texas | 77372 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02426918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2019 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02426918 live on ClinicalTrials.gov.